IMDX
Insight Molecular Diagnostics Inc.

3,667
Mkt Cap
$192.97M
Volume
101,078.00
52W High
$8.51
52W Low
$2.33
PE Ratio
-2.12
IMDX Fundamentals
Price
$6.01
Prev Close
$5.67
Open
$5.72
50D MA
$6.38
Beta
0.72
Avg. Volume
34,521.70
EPS (Annual)
-$4.66
P/B
-18.71
Rev/Employee
$38,387.75
$26.14
Loading...
Loading...
News
all
press releases
Oncocyte (NASDAQ:IMDX) Price Target Raised to $12.00
Lake Street Capital boosted their price target on shares of Oncocyte from $8.00 to $12.00 and gave the stock a "buy" rating in a research note on Tuesday...
MarketBeat·12d ago
News Placeholder
More News
News Placeholder
Insider Buying: Oncocyte (NASDAQ:IMDX) Major Shareholder Acquires 521,739 Shares of Stock
Oncocyte Corp (NASDAQ:IMDX - Get Free Report) major shareholder Broadwood Partners, L.P. bought 521,739 shares of Oncocyte stock in a transaction that occurred on Tuesday, February 10th. The stock...
MarketBeat·17d ago
News Placeholder
Oncocyte (NASDAQ:IMDX) Trading 9.4% Higher - What's Next?
Oncocyte (NASDAQ:IMDX) Shares Up 9.4% - Here's What Happened...
MarketBeat·23d ago
News Placeholder
Oncocyte (NASDAQ:IMDX) Shares Down 3.4% - Should You Sell?
Oncocyte (NASDAQ:IMDX) Trading Down 3.4% - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk
AI momentum and rising demand for digital care put Zacks Medical Info Systems industry stocks like VEEV, TXG and IMDX in focus despite new tariff headwinds.
Zacks·8mo ago
<
...
1
>

Latest IMDX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.